Goldman Sachs’s Cytokinetics CYTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-35,000
Closed -$2.22M 6583
2025
Q4
$2.22M Buy
35,000
+5,000
+17% +$311K ﹤0.01% 4495
2025
Q3
$1.65M Sell
30,000
-9,200
-23% -$379K ﹤0.01% 4643
2025
Q2
$1.3M Buy
39,200
+30,100
+331% +$1.05M ﹤0.01% 4512
2025
Q1
$366K Buy
+9,100
New +$418K ﹤0.01% 5368
2024
Q4
Sell
-47,500
Closed -$2.51M 6070
2024
Q3
$2.51M Sell
47,500
-17,800
-27% -$992K ﹤0.01% 3952
2024
Q2
$3.54M Buy
65,300
+47,300
+263% +$2.86M ﹤0.01% 3478
2024
Q1
$1.26M Sell
18,000
-184,100
-91% -$14.2M ﹤0.01% 4189
2023
Q4
$16.9M Buy
+202,100
New +$7.32M ﹤0.01% 2062
2020
Q4
Sell
-107,300
Closed -$2.32M 5520
2020
Q3
$2.32M Buy
+107,300
New +$2.51M ﹤0.01% 3458
2016
Q4
Sell
-26,800
Closed -$246K 6917
2016
Q3
$246K Buy
+26,800
New +$280K ﹤0.01% 5641
2015
Q3
Sell
-75,000
Closed -$504K 7301
2015
Q2
$504K Hold
75,000
﹤0.01% 5203
2015
Q1
$509K Sell
75,000
-25,000
-25% -$187K ﹤0.01% 5109
2014
Q4
$801K Buy
+100,000
New +$429K ﹤0.01% 4818
2014
Q3
Sell
-38,200
Closed -$183K 7138
2014
Q2
$183K Sell
38,200
-130,100
-77% -$794K ﹤0.01% 6260
2014
Q1
$1.6M Buy
+168,300
New +$1.52M ﹤0.01% 4196

Other funds holding CYTK